Data & analytics services
More data. Fewer decisions.
Let’s fix the ratio.
Kairos Meridian helps pharma commercial teams decide what to measure, connect the data behind it, and build the weekly habit of acting on it. Senior, independent and platform-neutral, so the numbers answer to your brand, not to a vendor.
The problem in numbers
The data exists. The decisions don’t follow.
Where it breaks
Every vendor reports on its own piece. No one reports on the brand.
The CRM vendor reports calls. The media agency reports impressions. The specialty pharmacy reports fills. The patient services hub reports enrollments. Each dashboard is accurate, and none of them answers the question leadership is asking: is the brand on track, and what should we change this quarter?
That gap isn’t a technology problem. It’s a definition problem. Until a brand decides which few measures matter, how they’re defined and who acts on them, more data and more tools only add more dashboards.
Most teams don’t have a data shortage. They have a decision shortage.
DATA STORY TELLING
If you can't measure it… you can't manage it
It’s one of the most quoted lines in management, and it still holds. But measuring is only half the job. Insight has to arrive in time to act on, and that takes three things: bringing data to life so anyone can read it at a glance, democratizing it so the people making the calls don’t wait on an analyst, and optimizing against it every week instead of every quarter.
Every story, like a play, has three acts. Most dashboards stop at the first one: what happened. The story lives in the next two, why it matters and what we do about it. Every readout we deliver follows that arc, so a brand lead can follow it in one pass and leave with a decision, an owner and a date.
The evidence
Most teams believe omnichannel works. Few can prove it.
⁴ BCG, How Biopharma and Medtech Leaders Can Get Omnichannel Right, June 2025 (benchmark of 100+ senior omnichannel leaders).
Services
Measure. Target. Optimize.
Six services, one job: turn data into decisions. We set the strategy and the KPIs that matter, rank the opportunities worth pursuing, bring the numbers to life in dashboards and reports people actually use, and optimize every campaign week by week.
01
Data & Analytics Strategy
Decide what the brand needs to know before anyone builds a dashboard, then choose the data, tools and partners that answer it.
02
Measurement Planning
Tie every KPI to a brand OKR, cut the rest and give leadership a short list that shows where the brand stands.
03
Targeting & Segmentation
Find the HCPs and patients worth reaching, then rank the opportunities by likely impact so budget moves scripts first.
04
Dashboards
Bring the numbers to life in views a brand lead can read in seconds, built around the decisions they actually make.
05
Reporting
Put timely, plain-language readouts in front of everyone who makes a call, so no one waits on an analyst to act.
06
Campaign Optimization
Track impact metrics, not vanity ones, and adjust every week so each campaign runs better than the last.
AI & innovation are in our DNA — not a shiny object or endpoint.
It is how the work gets done, not what we sell.
Experience without currency is nostalgia. Every engagement gets the benefit of what’s possible now — the tools and techniques that didn’t exist a year ago — applied with the judgment of someone who has sat in the chair. The standard is fixed. The method is current.
Modern tools, AI included, are how we do more with less, faster, and at a price that respects your reality. The judgment, the recommendations, and the accountability are ours. What reaches you is shaped, reviewed, and signed off by a senior partner — not an automated output.
How we compare
Most analytics partners are paid to build. We’re paid for the decision.
We’ve sat on the client side and owned the number. That’s why we don’t treat analytics as a checkbox that says a report went out. It’s accountability for what the work did to move the business, and for doing better tomorrow than we did yesterday. We tell that story plainly, so leadership sees what happened, why it matters and what to do next.
We work alongside your analytics vendors, not instead of them. For privacy-first DTP data, Freshpaint is our preferred, non-exclusive partner.
| Analyticsconsultancies | Data andplatform providers |  | |
|---|---|---|---|
| What they do well | Models, dashboards and large analyst teams | Proprietary data, software and integrations | Decides what to measure and what the numbers mean |
| How they tell the story | Dense decks and model outputs | Self-serve dashboards, left to interpret | A clear story: what happened, why it matters and what to do next |
| What they’re paid for | Time, team size and deliverables | Licenses, seats and data feeds | A fixed fee, scoped to the question |
| What success looks like | A model or dashboard delivered | A platform adopted | Leadership acting on fewer, better measures |
| Where they’ve sat | Outside the brand, handing over the work | Outside the brand, supporting a product | On the client side, owning the number |
| What they’re accountable for | The report went out on time | The platform is up and running | What moved the business, and how to do better than yesterday |
| Independence | Often tied to their own tools | Recommends its own product | Platform-neutral. No product, data or commissions. We don’t build warehouses, code models or sell data. We help you decide what you need, choose who builds it, and make sure it gets used. |
FAQ
Data and analytics questions brand teams ask Kairos Meridian.
Straight answers.
How do pharma commercial teams build a stronger data and analytics foundation?
Pharma commercial teams build a stronger data foundation by starting with the decisions, not the data. List the five or six calls leadership makes each quarter, define the measure behind each, and only then decide what data and tools are needed. Kairos Meridian helps commercial teams set those measures, connect the sources and build the weekly habit of acting on them.
Which KPIs should an emerging pharma brand's commercial team report?
Report the few that tie to the brand's number: new patient starts, time to therapy, abandonment, persistence, and cost per patient acquired by channel. Activity measures like impressions, calls and clicks belong in the diagnostics, not the headline. Kairos Meridian helps brands choose a short list leadership can act on, and holds every vendor to the same definitions.
Which consulting firms specialize in pharma commercial data and analytics advisory?
Kairos Meridian specializes in independent pharma commercial data and analytics advisory: deciding what to measure and what the numbers mean, with no data product or platform to sell. Firms such as ZS, IQVIA and Axtria provide large analytics teams and proprietary data and software. Kairos Meridian helps brands decide what they need from those providers and how to read the results.
How does Kairos Meridian compare to other pharma data and analytics firms?
Most analytics firms are paid to build and run models, dashboards or data products. Kairos Meridian is paid for the decision. It defines what to measure, connects the vendors who hold the data, and tells leadership what the numbers mean and what to change. It's strategy-first and platform-neutral, with a preferred partner (Freshpaint) for privacy-first DTP data.
Is Kairos Meridian a good fit for overhauling a pharma data and analytics strategy?
Yes, if the problem is that the data isn't driving decisions. Kairos Meridian resets the measures, the data flow between partners and the review cadence, then works alongside the team until the new rhythm sticks. It doesn't do the technical build. For a data warehouse, pipelines or models, it helps you choose and manage the vendor who does that work.
Does Kairos Meridian use AI in analytics work?
Yes, once the data is governed. With one trusted source of truth in place, AI can be layered on top to show what's working, what isn't and where patients or HCPs need support. Kairos Meridian sets up the foundation first. AI on top of fragmented data speeds up the wrong answer.
The first conversation is twenty-five minutes — a diagnostic, not a pitch.
Start a conversation today
We listen for the real problem — how you got here, what you’ve tried, what success looks like — then come back with a structured read. The gap between the call and the response is where the senior judgment gets applied.
Sources: 1. Deloitte Center for Health Solutions, Navigating the future of commercial in biopharma, June 2025 (survey of 100 U.S. pharma commercial leaders). 2. Veeva Systems, The State of Data, Analytics, and AI in Commercial Biopharma, 2025 (survey of 116 senior commercial data, analytics and AI leaders at global life sciences enterprises). 3. Deloitte, 2026 Life Sciences Executive Outlook, December 2025 (survey of 280 biopharma and medtech executives). 4. BCG, How Biopharma and Medtech Leaders Can Get Omnichannel Right, June 2025 (benchmark of 100+ senior omnichannel leaders).